TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma.
Saved in:
| Title: | TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma. |
|---|---|
| Authors: | Gross L; Christine Kühne - Center for Allergy Research and Education, 7265 Davos, Switzerland.; Graduate School Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland., Mutisheva I; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Hillen H; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Robatel S; Graduate School Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Wartenberg M; Division of Surgical Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Ma F; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA., Bäriswyl L; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Lee DJ; The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA.; Division of Dermatology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Modlin RL; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Division of Dermatology, School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Z'graggen K; Swiss Pancreas Clinic, 3013 Bern, Switzerland., Schenk M; Christine Kühne - Center for Allergy Research and Education, 7265 Davos, Switzerland.; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland. |
| Source: | Molecular therapy. Oncology [Mol Ther Oncol] 2025 Aug 14; Vol. 33 (3), pp. 201034. Date of Electronic Publication: 2025 Aug 14 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40917508 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gross+L%22">Gross L</searchLink>; Christine Kühne - Center for Allergy Research and Education, 7265 Davos, Switzerland.; Graduate School Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mutisheva+I%22">Mutisheva I</searchLink>; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hillen+H%22">Hillen H</searchLink>; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Robatel+S%22">Robatel S</searchLink>; Graduate School Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wartenberg+M%22">Wartenberg M</searchLink>; Division of Surgical Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ma+F%22">Ma F</searchLink>; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.<br /><searchLink fieldCode="AU" term="%22Bäriswyl+L%22">Bäriswyl L</searchLink>; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lee+DJ%22">Lee DJ</searchLink>; The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA.; Division of Dermatology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.<br /><searchLink fieldCode="AU" term="%22Modlin+RL%22">Modlin RL</searchLink>; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Division of Dermatology, School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.<br /><searchLink fieldCode="AU" term="%22Z'graggen+K%22">Z'graggen K</searchLink>; Swiss Pancreas Clinic, 3013 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schenk+M%22">Schenk M</searchLink>; Christine Kühne - Center for Allergy Research and Education, 7265 Davos, Switzerland.; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918752083706676%22">Molecular therapy. Oncology</searchLink> [Mol Ther Oncol] 2025 Aug 14; Vol. 33 (3), pp. 201034. <i>Date of Electronic Publication: </i>2025 Aug 14 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918752083706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2950-3299 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503299%22">29503299 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncol <i>Subsets: </i>In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40917508 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.omton.2025.201034 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 201034 Titles: – TitleFull: TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gross L – PersonEntity: Name: NameFull: Mutisheva I – PersonEntity: Name: NameFull: Hillen H – PersonEntity: Name: NameFull: Robatel S – PersonEntity: Name: NameFull: Wartenberg M – PersonEntity: Name: NameFull: Ma F – PersonEntity: Name: NameFull: Bäriswyl L – PersonEntity: Name: NameFull: Lee DJ – PersonEntity: Name: NameFull: Modlin RL – PersonEntity: Name: NameFull: Z'graggen K – PersonEntity: Name: NameFull: Schenk M IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 08 Text: 2025 Aug 14 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2950-3299 Numbering: – Type: volume Value: 33 – Type: issue Value: 3 Titles: – TitleFull: Molecular therapy. Oncology Type: main |
| ResultId | 1 |